US Stock MarketDetailed Quotes

Acrivon Therapeutics (ACRV)

Watchlist
  • 1.560
  • +0.010+0.65%
Close Apr 10 16:00 ET
  • 1.510
  • -0.050-3.21%
Post 20:01 ET
60.44MMarket Cap-0.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics (ACRV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-5.70%84.11M
-19.39%20.12M
-21.69%19.69M
5.65%22.65M
22.61%21.66M
32.93%89.2M
18.53%24.95M
55.79%25.14M
38.13%21.44M
22.75%17.67M
Selling and administrative expenses
-4.30%24.12M
-15.09%5.37M
-3.78%6.04M
0.86%6.47M
0.86%6.25M
19.58%25.21M
13.43%6.32M
6.92%6.28M
28.27%6.41M
33.66%6.2M
-General and administrative expense
-4.30%24.12M
-15.09%5.37M
-3.78%6.04M
0.86%6.47M
0.86%6.25M
19.58%25.21M
13.43%6.32M
6.92%6.28M
28.27%6.41M
33.66%6.2M
Research and development costs
-6.25%59.99M
-20.85%14.75M
-27.65%13.65M
7.70%16.18M
34.35%15.41M
39.04%63.99M
20.36%18.63M
83.73%18.86M
42.81%15.03M
17.58%11.47M
Operating profit
5.70%-84.11M
19.39%-20.12M
21.69%-19.69M
-5.65%-22.65M
-22.61%-21.66M
-32.93%-89.2M
-18.53%-24.95M
-55.79%-25.14M
-38.13%-21.44M
-22.75%-17.67M
Net non-operating interest income expense
-29.58%6.48M
-47.23%1.25M
-44.18%1.51M
-35.78%1.73M
38.04%2M
30.75%9.2M
39.66%2.36M
52.60%2.7M
52.20%2.69M
-19.98%1.45M
Non-operating interest income
-29.58%6.48M
-47.23%1.25M
-44.18%1.51M
-35.78%1.73M
38.04%2M
30.75%9.2M
39.66%2.36M
52.60%2.7M
52.20%2.69M
-19.98%1.45M
Other net income (expense)
51.61%-270K
51.67%-116K
-5,400.00%-53K
-58.18%-87K
94.70%-14K
-73.29%-558K
-320.18%-240K
101.03%1K
66.46%-55K
-55.29%-264K
Other non- operating income (expenses)
51.61%-270K
51.67%-116K
-5,400.00%-53K
-58.18%-87K
94.70%-14K
-73.29%-558K
-320.18%-240K
101.03%1K
66.46%-55K
-55.29%-264K
Income before tax
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Income tax
Net income
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Net income continuous Operations
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Minority interest income
Net income attributable to the parent company
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Basic earnings per share
15.13%-2.02
18.33%-0.49
20.34%-0.47
-5.77%-0.55
30.14%-0.51
13.14%-2.38
31.03%-0.6
10.61%-0.59
17.46%-0.52
-25.86%-0.73
Diluted earnings per share
15.13%-2.02
18.33%-0.49
20.34%-0.47
-5.77%-0.55
30.14%-0.51
13.14%-2.38
31.03%-0.6
10.61%-0.59
17.46%-0.52
-25.86%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -5.70%84.11M-19.39%20.12M-21.69%19.69M5.65%22.65M22.61%21.66M32.93%89.2M18.53%24.95M55.79%25.14M38.13%21.44M22.75%17.67M
Selling and administrative expenses -4.30%24.12M-15.09%5.37M-3.78%6.04M0.86%6.47M0.86%6.25M19.58%25.21M13.43%6.32M6.92%6.28M28.27%6.41M33.66%6.2M
-General and administrative expense -4.30%24.12M-15.09%5.37M-3.78%6.04M0.86%6.47M0.86%6.25M19.58%25.21M13.43%6.32M6.92%6.28M28.27%6.41M33.66%6.2M
Research and development costs -6.25%59.99M-20.85%14.75M-27.65%13.65M7.70%16.18M34.35%15.41M39.04%63.99M20.36%18.63M83.73%18.86M42.81%15.03M17.58%11.47M
Operating profit 5.70%-84.11M19.39%-20.12M21.69%-19.69M-5.65%-22.65M-22.61%-21.66M-32.93%-89.2M-18.53%-24.95M-55.79%-25.14M-38.13%-21.44M-22.75%-17.67M
Net non-operating interest income expense -29.58%6.48M-47.23%1.25M-44.18%1.51M-35.78%1.73M38.04%2M30.75%9.2M39.66%2.36M52.60%2.7M52.20%2.69M-19.98%1.45M
Non-operating interest income -29.58%6.48M-47.23%1.25M-44.18%1.51M-35.78%1.73M38.04%2M30.75%9.2M39.66%2.36M52.60%2.7M52.20%2.69M-19.98%1.45M
Other net income (expense) 51.61%-270K51.67%-116K-5,400.00%-53K-58.18%-87K94.70%-14K-73.29%-558K-320.18%-240K101.03%1K66.46%-55K-55.29%-264K
Other non- operating income (expenses) 51.61%-270K51.67%-116K-5,400.00%-53K-58.18%-87K94.70%-14K-73.29%-558K-320.18%-240K101.03%1K66.46%-55K-55.29%-264K
Income before tax 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Income tax
Net income 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Net income continuous Operations 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Minority interest income
Net income attributable to the parent company 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Basic earnings per share 15.13%-2.0218.33%-0.4920.34%-0.47-5.77%-0.5530.14%-0.5113.14%-2.3831.03%-0.610.61%-0.5917.46%-0.52-25.86%-0.73
Diluted earnings per share 15.13%-2.0218.33%-0.4920.34%-0.47-5.77%-0.5530.14%-0.5113.14%-2.3831.03%-0.610.61%-0.5917.46%-0.52-25.86%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -